SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-21-015899
Filing Date
2021-07-01
Accepted
2021-07-01 19:50:59
Documents
1
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 12823
  Complete submission text file 0001493152-21-015899.txt   15346
Mailing Address 1199 PARK AVENUE #17A NEW YORK NY 10128
Business Address
Silvers Daniel B. (Reporting) CIK: 0001468195 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38306 | Film No.: 211067688

Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Issuer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 250 WEST 57TH STREET SUITE 2223 NEW YORK NY 10107
Business Address 250 WEST 57TH STREET SUITE 2223 NEW YORK NY 10107 646.820.0860
MLCP GLL Funding LLC (Reporting) CIK: 0001722935 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-38306 | Film No.: 211067686

Mailing Address 250 WEST 57TH STREET SUITE 2223 NEW YORK NY 10107
Business Address 250 WEST 57TH STREET SUITE 2223 NEW YORK NY 10107 646.820.0860
Matthews Lane Capital Partners LLC (Reporting) CIK: 0001722952 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-38306 | Film No.: 211067687